Silent, but deadly--eliminating reservoirs of latent HIV.
D019380:Anti-HIV Agents / Q000378:metabolism / Q000494:pharmacology*; D002352:Carrier Proteins / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000379:methods*; D015700:HIV Envelope Protein gp41 / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D010455:Peptides / Q000627:therapeutic use*; D011994:Recombinant Proteins; D017735:Virus Latency / Q000187:drug effects*
C420917:5-helix protein, synthetic; D019380:Anti-HIV Agents; D002352:Carrier Proteins; D015700:HIV Envelope Protein gp41; D010455:Peptides; D011994:Recombinant Proteins